首页 | 官方网站   微博 | 高级检索  
     

bFGF反义寡核苷酸增强鼠黑色素瘤B16细胞化疗药物敏感性研究
引用本文:黄红亮,王宏,唐勇,邓宁,杨红宇,向军俭.bFGF反义寡核苷酸增强鼠黑色素瘤B16细胞化疗药物敏感性研究[J].现代生物医学进展,2007,7(10):1477-1480.
作者姓名:黄红亮  王宏  唐勇  邓宁  杨红宇  向军俭
作者单位:暨南大学,分子免疫与抗体工程中心,广东,广州,510632
摘    要:目的:研究bFGF反义硫代寡核苷酸增强肿瘤细胞对化疗药物敏感性作用。方法:设计、合成bFGF寡核苷酸,用聚乙烯亚胺(polyemyleneimine,PEI)介导bFGF反义硫代寡核苷酸转染入黑色素瘤B16细胞,MTT法检测bFGF反义硫代寡核苷酸及其与化疗药物联合处理后的细胞增殖率;半定量RT-PCR测定bFGF反义硫代寡核苷酸转染后细胞中bFGF mRNA水平;流式细胞仪分析bFGF反义硫代寡核苷酸诱导的细胞凋亡。结果:bFGF反义硫代寡核苷酸对B16细胞增殖的抑制率为64.8%,且呈剂量依赖效应。B16细胞中bFGF mRNA被bFGF反义硫代寡核苷酸显著降低,为对照细胞的57.9%,且bFGF反义硫代寡核苷酸诱导B16细胞凋亡,凋亡率为41.8%。bFGF反义硫代寡核苷酸转染能显著增强B16细胞对阿霉素、5-氟脲嘧啶及顺铂的敏感性,非特异性硫代寡核苷酸不影响阿霉素、5-氟脲嘧啶及顺铂抑制B16细胞增殖。结论:bFGF反义硫代寡核苷酸显著增强B16细胞的化疗敏感性,表明其可协同化疗药物用于治疗肿瘤。

关 键 词:肿瘤  反义寡核苷酸  药物敏感性
文章编号:1673-6273(2007)10-1477-04
修稿时间:2007-07-03

Antisense Phosphorothioate Oligonucleotides Targeting bFGF Enhanced Chemosensitivity in Mouse Melanoma B16 Cells
HUANG Hong-liang,WANG Hong,TANG Yong,DENG Ning,YANG Hong-yu,XIANG Jun-jian.Antisense Phosphorothioate Oligonucleotides Targeting bFGF Enhanced Chemosensitivity in Mouse Melanoma B16 Cells[J].Progress in Modern Biomedicine,2007,7(10):1477-1480.
Authors:HUANG Hong-liang  WANG Hong  TANG Yong  DENG Ning  YANG Hong-yu  XIANG Jun-jian
Affiliation:Antibody engineering center, Jinan University, Guangzhou, Guangdong 510632, China
Abstract:Objective:To detect whether a specific antisense phosphorothioate oligonucleotide targeting bFGF enhance chemosensitivity of carcinomas.Methods:bFGF-specific antsense phosphorothioate oligonuleotides were transfected into mouse melanoma 1316 cell lines with jetPEI(polyethyleneimine).The relative cell proliferation was analyzed by MTT assay,bFGF mRNA level was evaluated by semi-quantitative RT-PCR,and apoptosis of the B 16 cells induced by antisense phosphorothioate oligonucleotides tar- geting bFGF was analyzed by flow cytometry.Cell proliferation was then analyzed after treatment with both bFGF-specific antsense phosphorothioate oligonuleotides and chemotherapeutic drugs by MTT assay.Results:bFGF-specific antisense phosphorothioate oligonuleotides inhibited the growth of B 16 cells by 64.8% in a dose and time-dependent manner,significantly reduced the bFGF mRNA level to 57.9% of control cells,and induced apoptosis by 41.8%.Compared to nonspecific phosphorothioate oligonuleotides,bFGF-spe- cific antisense phosphorothioate could significantly enhance chemosensitivity of B 16 cells to adriamycin(ADM),5-fluorouracil(5-FU), and cis-diaminodichloroptatin(DDP).Conclusion:bFGF-specific antisense phosphorothioate oligonucleotides have therapeutic effects on mouse melamoma B16 cells,and are a potential antitumor agent combined with chemotherapeutic drugs.
Keywords:bFGF
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号